Australia’s Pharma Regulator Suppressed Troubling Report about Pfizer COVID-19 Vaccine

1 year ago
404

Recently, Australia’s Therapeutic Goods Administration (TGA) made a report from 2021 available to the public. Titled “Nonclinical Evaluation Report BNT162b2 [mRNA] COVID-19 Vaccine (COMIRNATYTM)” the document provides inputs from the preclinical work involving the Pfizer-BioNTech mRNA vaccine BNT162b2 (Comirnaty) via Pfizer Australia pty Ltd. A bombshell actually, the TGA, the agency that is supposed to “safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods” seemingly let the pharmaceutical company in this case dictate the risk-benefit analysis. At the height of the pandemic and the onset of the mass COVID-19 vaccination rollout starting February 22, 2021, the data in this document wasn’t shared with the public. But why not? Would the data (or lack thereof) associated with this report lead to more vaccine hesitancy?

------------------------------------
Join The Conversation! | https://trialsitenews.com/

Loading 1 comment...